Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer

NCT01688609 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

HER2-positive Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer

Interventions

DRUG: lapatinib ditosylate
DRUG: paclitaxel
BIOLOGICAL: trastuzumab
PROCEDURE: therapeutic conventional surgery
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)